Brought to you by 
Roche pays Agouron, Japan Tobacco $40mm for Viracept
13 Jul 1999
Executive Summary
Roche agreed to pay Agouron and Japan Tobacco $40mm plus sales royalties for exclusive marketing rights to Viracept, an anti-HIV drug (nelfinavir mesylate), in Europe and territories outside North America, Japan and Asia.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Roche pays Agouron, Japan Tobacco $40mm for Viracept
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice